Vetoquinol SA

Report Publication Announcement • Jul 31, 2014

VÉTOQUINOL PUBLISHES ITS HALF YEAR FINANCIAL REPORT RELATIVE TO FISCAL YEAR 2014 (FRENCH VERSION)

The half year financial report relative to fiscal year 2014 can be read or downloaded on the websites of:

• Vétoquinol (www.vetoquinol.com)
• the AMF (www.amf-france.org)

It is also available to the public free of charge upon simple request:

• by mail: Vétoquinol Communication financière Magny-Vernois – BP 189 – 70204 Lure Cedex - France - by e-mail: relations.investisseurs@vetoquinol.com
• by phone: +33 (0)3 84 62 59 88

About Vétoquinol

Vétoquinol is an independent, family-owned business, global player in the animal health sector serving both the livestock (cattle and swine) and pet (dogs and cats) markets. Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation and geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high growth markets. Vétoquinol employs over 1,950 people globally. Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

For more information: www.vetoquinol.com.

OUR BUSINESS: ANIMALS. OUR ADVANTAGE: PEOPLE.

For more information, contact:

VETOQUINOL KEIMA COMMUNICATION Investor Relations Régis VIMAL DU MONTEIL Tel.: + 33 (0)3 84 62 59 88 relations.investisseurs@vetoquinol.com

Investor Relations & Media Relations Emmanuel DOVERGNE Tel.: +33 (0)1 56 43 44 63 emmanuel.dovergne@keima.fr